Early-onset Parkinson disease
Gene: COQ2
COQ2 encodes a key enzyme in coenzyme Q10 biosynthesis and is implicated in multiple system atrophy (MSA).
Multiple system atrophy, autosomal recessive – early‑onset Parkinsonism, cerebellar ataxia and autonomic dysfunction. Five independent families (6 reported patients) carry biallelic COQ2 variants (nonsense and missense) reported in PMID 30242188, 23758206, 25672683; iPSC‑derived neuronal rescue and yeast complementation support pathogenicity. But only 2 families were without a common missense V393A, which is present at a frequency of 2% in the East Asian population.
Multiple system atrophy, autosomal dominant – Parkinsonian type, early‑onset. Five affected individuals from a single pedigree harbour a heterozygous p.Ala301Thr missense variant (PMID 39152783); segregation across three generations is demonstrated, but no functional validation is available.
Multiple system atrophy risk allele – heterozygous COQ2 missense variants (including V393A) identified in a case‑control cohort of 758 patients (PMID 25672683). The high carrier frequency (3.3 % in controls) and lack of segregation indicate a susceptibility rather than a Mendelian disease.
Sources: LiteratureCreated: 20 Jun 2026, 3:15 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
multiple system atrophy, MONDO:0007803
Publications
Gene: coq2 has been classified as Amber List (Moderate Evidence).
Gene: coq2 has been classified as Amber List (Moderate Evidence).
gene: COQ2 was added gene: COQ2 was added to Early-onset Parkinson disease. Sources: Literature Mode of inheritance for gene: COQ2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: COQ2 were set to 39152783; 30242188; 25672683; 23758206 Phenotypes for gene: COQ2 were set to multiple system atrophy, MONDO:0007803 Review for gene: COQ2 was set to AMBER